Is the Lloyds share price outstanding value or a value trap?

G A Chester discusses popular FTSE 100 stock Lloyds, where all the popular indicators of value are screaming ‘buy’.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The ‘Boris bounce’ didn’t last long for Lloyds (LSE: LLOY). Its share price peaked at 67.25p on 16 December, the Monday after the general election. By mid-January, it was back below 60p. The market evidently had second thoughts about the FTSE 100 bank’s prospects long before its results last week and the broad market sell-off this week.

The shares closed yesterday at 52p. Most brokers, analysts and media tipsters are bullish on the stock, as they have been for years. Indeed, a majority reckon it offers outstanding value. Against that, a not insignificant minority argue it’s a value trap. I’ve been in the latter camp for a good while. But I think it’s now quite a conundrum. I’m asking myself if it could finally be time to back the Black Horse.

Cheap

Purely on the common numerical indicators of value, Lloyds looks cheap. The current share price is 1.02 times the tangible net asset value (TNAV) of 50.8p a share reported in its results.

It’s at 14.9 times earnings of 3.5p a share. And with earnings forecast to zoom to 6.8p this year, the multiple comes down to just 7.6.

Meanwhile, a dividend of 3.37p gives a yield of 6.5%. And this is expected to rise to 6.7% this year on forecasts of an increase in the payout to 3.5p.

As I say, Lloyds looks cheap.

Economic cycle

Banks are highly geared to the health of the wider economy. As such, they fare badly in an economic downturn. There’s a risk the spread of the coronavirus could tip the global economy into a recession, and a risk the Brexit divorce could spark a UK recession too.

Even if neither happens, Lloyds will face a recession at some point. And with the current economic cycle looking long in the tooth by historical standards, a recession is looming ever closer on the horizon. Furthermore, with UK consumers and businesses over-indebted and under-saved like never before, this recession could be a particularly severe one.

Rising bad debts

Insolvency specialist Begbies Traynor has been tracking the health of the UK economy since 2004 in its quarterly ‘Red Flag Alert’ reports. The latest shows that at the end of 2019, almost half a million UK businesses were in “significant financial distress” — the highest level since its reports began.

Lloyds’ latest results, may be an unpleasant taste of things to come. It reported a 38% rise in bad debt impairments to £1.3bn (on a pre-impairment profit of £8.8bn). In the last recession, impairments reached £16.7bn.

Here’s what I’d buy

Lloyds undoubtedly looks cheap on the valuation metrics. I’m almost tempted, but at this stage of the economic cycle I’m still more inclined to see it as a value trap, and to avoid it. Particularly, as the recent market sell-off means many quality defensive businesses are now trading at attractive valuations.

If I was in the market for blue-chip stocks today, I’d be buying Diageo, GlaxoSmithKline and Unilever (among others). Plus one or two of my favoured recovery prospects, notably BT.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended Diageo and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

The flag of the United States of America flying in front of the Capitol building
Investing Articles

3 top S&P 500 growth shares to consider buying for a Stocks and Shares ISA in 2025

Edward Sheldon has picked out three S&P 500 stocks that he believes will provide attractive returns for investors in the…

Read more »

Growth Shares

Can the red hot Scottish Mortgage share price smash the FTSE 100 again in 2025?

The Scottish Mortgage share price moved substantially higher in 2024. Edward Sheldon expects further gains next year and in the…

Read more »

Inflation in newspapers
Investing Articles

2 inflation-resistant growth stocks to consider buying in 2025

Rising prices are back on the macroeconomic radar, meaning growth prospects are even more important for investors looking for stocks…

Read more »

Investing Articles

Why I’ll be avoiding BT shares like the plague in 2025

BT shares are currently around 23% below the average analyst price target for the stock. But Stephen Wright doesn’t see…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

5 Warren Buffett investing moves I’ll make in 2025

I’m planning to channel Warren Buffett in 2025. I won’t necessarily buy the same stocks as him, but I’ll track…

Read more »

Investing Articles

Here’s why 2025 could be make-or-break for this FTSE 100 stock

Diageo is renowned for having some of the strongest brands of any FTSE 100 company. But Stephen Wright thinks it’s…

Read more »

Investing Articles

1 massive Stocks and Shares ISA mistake to avoid in 2025!

Harvey Jones kept making the same investment mistake in 2024. Now he aims to put it right when buying companies…

Read more »

Value Shares

Can Lloyds shares double investors’ money in 2025?

Lloyds shares look dirt cheap today. But are they cheap enough to be able to double in price in 2025?…

Read more »